Finance International is an additional Finance product and delivers international news in English from various sources (Bloomberg, Project Syndicate).
Click here to receive an e-mail alert each time a new International article is published. 
FINANCE
International
The High Cost of Eating Out in America
International
International© Bloomberg Businessweek The High Cost of Eating Out in America
FINANCE
International
How Bad Movie Dubbing Led to the Fake Biden Campaign Robocalls
FINANCE
International
NFTs, a Punchline During Crypto Bust, Attempt a Comeback
FINANCE
International
Ozempic to Send Foodmakers Looking for Healthier Offerings
FINANCE
International
What’s Really Behind Tesla’s Slowdown
International
International© Bloomberg Businessweek What’s Really Behind Tesla’s Slowdown

And how one of the biggest obstacles facing electric vehicle maker is its CEO.

FINANCE
International
OpenAI’s Secret Weapon Is Sam Altman’s 33-Year-Old Lieutenant
FINANCE
International
Can I Hire My Crush?
International
International© Bloomberg Businessweek Can I Hire My Crush?
FINANCE
International
Novartis Buys MorphoSys for €2.7 Billion to Get Cancer Drugs
FINANCE
International
Artificial Intelligence vs. Human Stupidity
FINANCE
International
Reform Antitrust and Patent Laws Now
International
InternationalProject Syndicate Reform Antitrust and Patent Laws Now
FINANCE
International
Streaming Pirates Are Hollywood’s New Villains
International
International© Bloomberg Businessweek Streaming Pirates Are Hollywood’s New Villains
FINANCE
International
Are Electric Cars a Dead End?
International
InternationalProject Syndicate Are Electric Cars a Dead End? 5
FINANCE
International
AI Needs So Much Power That Old Coal Plants Are Sticking Around
International
International© Bloomberg Businessweek AI Needs So Much Power That Old Coal Plants Are Sticking Around

Power companies are scrambling to satisfy the needs of data centers and new factories in a country where the grid is already strained.

FINANCE
International
Sanofi to Buy Inhibrx for $2.2 Billion in Rare-Disease Push